Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients

Complementary Therapies in Medicine

Volumn 18, Issue 3-4, 2010, Pages 171-174

  Caughey, Gillian E ^a   James, Michael J ^b   Proudman, Susanna M ^b   Cleland, Leslie G ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Arthritis; Eicosanoids; Fish oil; Paracetamol

Indexed keywords

FATTY ACID; FISH OIL; HYDROXYCHLOROQUINE; ICOSAPENTAENOIC ACID; METHOTREXATE; OMEGA 3 FATTY ACID; PARACETAMOL; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SALAZOSULFAPYRIDINE; THROMBOXANE A2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG POTENTIATION; ENZYME INHIBITION; FATTY ACID BLOOD LEVEL; HUMAN; PROSTAGLANDIN SYNTHESIS; RHEUMATOID ARTHRITIS;

ACETAMINOPHEN; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG SYNERGISM; EICOSAPENTAENOIC ACID; HUMANS; PHOSPHOLIPIDS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THROMBOXANE A2;

EID: 77955326446     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2010.05.032     Document Type: Article

References (18)

1. van der Linden M.W., van der Bij S., Welsing P., Kuipers E.J., Herings R.M. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2009, 68:668-673.
2. National Prescribing Service Elevated cardiovascular risk with NSAIDs? 2005.
3. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000, 43:1905-1915.
4. Towheed T.E., Maxwell L., Judd M.G., Catton M., Hochberg M.C., Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, 25. CD004257.
5. National Prescribing Service NPS News 47: Analgesic options for pain relief 2006.
6. Goldberg R.J., Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129:210-223.
7. von Schacky C., Harris W.S. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 2007, 73:310-315.
8. Cleland L.G., James M.J., Proudman S.M. Fish oil: what the prescriber needs to know. Arthritis Res Ther 2005, 8:202.
9. Hanel A.M., Lands W.E.M. Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol 1982, 31:3307-3311.
10. Smith W.L., Lands W.E. Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular gland. Biochemistry 1972, 11:3276-3285.
11. Proudman S.M., Cleland L.G., James M.J. Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility. Rheum Dis Clin North Am 2008, 34:469-479.
12. Lands W.E. Biosynthesis of prostaglandins. Annu Rev Nutr 1991, 11:41-60.
13. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
14. Proudman S.M., Keen H.I., Stamp L.K., Lee A.T., Goldblatt F., Ayres O.C., et al. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum 2007, 37:99-111.
15. Cleland L.G., Caughey G.E., James M.J., Proudman S.M. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. J Rheumatol 2006, 33:1973-1979.
16. Caughey G.E., Cleland L.G., Penglis P.S., Gamble J.R., James M.J. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001, 167:2831-2838.
17. Meyer B.J., Mann N.J., Lewis J.L., Milligan G.C., Sinclair A.J., Howe P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38:391-398.
18. Van Hecken A., Schwartz J.I., Depre M., De Lepeleire I., Dallob A., Tanaka W., et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol 2000, 40:1109-1120.